Danise Subramaniam

Danise Subramaniam is a highly experienced professional in the biochemistry and pharmaceutical sectors, currently serving as Senior Director at Regeneron Pharmaceuticals, Inc. since September 2020. Prior to this role, Danise held various senior positions at Eli Lilly and Company from December 2000 to September 2020, including Senior Director of Global Regulatory Affairs, Senior Advisor in Project Management, and Project Team Leader for the Immunology portfolio. Earlier career experiences include roles as Director of Program Phase Project Management, Manager of Project Management, and Principal Research Scientist, specializing in the discovery and early development of large molecule therapeutics. Additional leadership experience includes serving as a Board Member at VWHA from 2007 to 2012 and previous scientific roles at the University of Alabama Birmingham and The Dow Chemical Company. Danise holds a Ph.D. in Biochemistry from the University of Alabama at Birmingham and a BS in Biochemistry from the University of Nebraska-Lincoln.